Press Release

Glenmark to Commence Another New Phase 3 Clinical Trial on a Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *